Skip to main content
Project Data Sphere
menu
Data Sharing Platform
Social Media
Twitter
LinkedIn
Search form
Search
Symposium IX Information
About
About Project Data Sphere
Our Data-Sharing Philosophy
Board of Directors
Team
Collaborators and Supporters
CEO Roundtable on Cancer
FAQ
Contact
Research
Research Programs
External Control Arm
Images and Algorithms
Immune-Related Adverse Events
Rare Tumor Registries
Crowdsourcing
Global Oncology Big Data Alliance
PDS-RTI Collaboration
Data Platform
For Researchers
For Data Providers
SAS Analytic Tools
Other Data-Sharing Entities
Events & Symposia
FDA-PDS Symposia
Annual Meetings
Workshops & Panels
Journal Publications
All Articles
Featured Articles
Newsroom
PDS in the News
PDS Press Releases
Video Library
You are here
Home
POST MEETING SURVEY – FDA-PDS SYMPOSIUM IX RARE CANCER REGISTRIES
What did you find most valuable at the FDA-PDS Symposium IX Rare Cancer Registries?
Learning more about PDS and its registry initiatives
Learning how my organization can use / better use registries
Learning about the latest research and initiatives on this key topic
Learning more about topics that are important to me professionally
Learning the perspective of FDA representatives on topics discussed
Please list topics/speakers you would recommend for follow-up events.
Which program segment did you find most interesting?
Keynote talk by Dr. Fajgenbaum
Panel 1: How do rare cancer registries impact clinical decision making?
Panel 2: How do rare cancer registries advance drugs in development?
Fireside Chat: Generating clinical evidence for biomarker-driven indications with Dr. Bilenker
How can we improve the content and/or the experience for our next event?
Leave this field blank